Association of Postangioplasty Femoropopliteal Dissections With Outcomes After Drug-Coated Balloon Angioplasty in the Femoropopliteal Arteries

被引:15
|
作者
Giannopoulos, Stefanos [1 ]
Strobel, Aaron [1 ]
Rudofker, Eric [1 ]
Kovach, Christopher [1 ]
Schneider, Peter A. [2 ]
Armstrong, Ehrin J. [1 ]
机构
[1] Univ Colorado, Rocky Mt Reg VA Med Ctr, Div Cardiol, Denver, CO 80202 USA
[2] Univ Calif San Francisco, Div Vasc & Endovasc Surg, San Francisco, CA 94143 USA
关键词
dissection; endovascular therapy; drug-coated balloon; paclitaxel coated balloon; peripheral artery disease; LOWER-EXTREMITY; ENDOVASCULAR INTERVENTIONS; TASK-FORCE; DISEASE; MANAGEMENT; CALCIFICATION; CONSENSUS; PATTERNS; SURGERY; IMPACT;
D O I
10.1177/15266028211016441
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: Balloon angioplasty for the treatment of femoropopliteal lesions is often complicated by postangioplasty dissections. While dissections are known to affect patency and reintervention after balloon angioplasty, the association between dissections and major adverse limb event (MALE) after drug-coated balloon (DCB) angioplasty remains uncertain. Thus, the postangioplasty dissection and bailout stenting patterns were investigated. Materials and Methods: This was a single-center retrospective study enrolling patients with de novo femoropopliteal lesions treated with DCB with/without stenting. Postangioplasty target vessel dissection was graded based to the coronary artery classification grades A-F, with grade C-F considered "severe." Cox regression analysis was performed to examine the association of dissection severity with outcomes during 2-year follow up, among nonstented cases. Results: In 85.3% of the cases (N=203/238) a postangioplasty dissection was observed. The average dissection length was 55.57 mm (SD 36.71 mm), with 1 dissection present in 91.8% (N=180/196) and 2 or more dissections present in 8.2% (N=16/196). Dissection severity was grade A (19.8%), B (20.6%), C (23.1%), D (10.9%), E (10.1%), and F (0.8%). Bailout stenting was required in 40.4% of the patients, being more prevalent among grade C and grade E cases. Among 142 nonstented cases, dissections were present in 85.2%. A total of 75 (52.8%) of these dissections were grade A and B, while 46 (32.4%) were grade C to F. Among nonstented cases, grade C (hazard ratio [HR] 5.83; 95% CI 1.25 to 27.31; p=0.025) and grade D (HR 6.32; 95% CI 1.39 to 28.86; p=0.017) vs grade A dissections were associated with a higher risk for 2-year MALE. Multivariate analysis adjusting for several lesion characteristics demonstrated a statistically significant higher risk for 2-year MALE among the severe dissection group (HR 2.94; 95% CI 1.27 to 6.79; p = 0.012). Interestingly, the risks of limb loss (HR 1.30; 95% CI 0.22 to 7.79; p=0.774) and repeat revascularization (HR 0.95; 95% CI 0.40 to 2.26; p=0.905) during follow-up were similar between the 2 groups. Conclusion: This study indicated that nonstented moderate and severe postangioplasty dissections after DCB angioplasty were associated with higher risk for MALE. Future studies are needed to validate our results and determine other dissection characteristics (eg, total dissection length, lumen area, total number of dissections) that may affect the efficacy of DCB.
引用
收藏
页码:593 / 603
页数:11
相关论文
共 50 条
  • [21] Midterm Outcome of Directional Atherectomy Combined with Drug-Coated Balloon Angioplasty Versus Drug-Coated Balloon Angioplasty Alone for Femoropopliteal Arteriosclerosis Obliterans
    Cai, Zhiwen
    Guo, Lianrui
    Qi, Lixing
    Cui, Shijun
    Tong, Zhu
    Guo, Jianming
    Wang, Zhonggao
    Gu, Yongquan
    ANNALS OF VASCULAR SURGERY, 2020, 64 : 181 - 187
  • [22] The Midterm Outcomes of Endovascular Therapy for Femoropopliteal Lesions via Drug-Coated Balloon, Directional Atherectomy and Bare Metal Stent Angioplasty
    Lin, Yuhao
    Quan, Jianjun
    Dong, Jian
    Cong, Longlong
    Yang, Lin
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (09)
  • [23] Predictors of recurrent restenosis after repeat drug-coated balloon therapy for drug-coated balloon restenosis in femoropopliteal lesions: Results of the RECURRENCE study
    Yanagiuchi, Takashi
    Fukai, Kuniyoshi
    Sogabe, Koji
    Iwasaki, Yoshihiro
    Hirano, Keita
    Kato, Taku
    Yokoi, Hirokazu
    Zen, Kan
    Matoba, Satoaki
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2024, 104 (06) : 1241 - 1250
  • [24] Two-Year Outcomes of Orbital Atherectomy Combined With Drug-Coated Balloon Angioplasty for Treatment of Heavily Calcified Femoropopliteal Lesions
    Kokkinidis, Damianos G.
    Jawaid, Omar
    Cantu, David
    Martinsen, Brad J.
    Igyarto, Zsuzsanna
    Valle, Javier A.
    Waldo, Stephen W.
    Armstrong, Ehrin J.
    JOURNAL OF ENDOVASCULAR THERAPY, 2020, 27 (03) : 492 - 501
  • [25] Evaluation of Mortality Following Paclitaxel Drug-Coated Balloon Angioplasty of Femoropopliteal Lesions in the Real World
    Boehme, Tanja
    Noory, Elias
    Beschorner, Ulrich
    Jacques, Borries
    Buergelin, Karlheinz
    Macharzina, Roland
    Gebauer, Ellen
    Cheung, Florian
    Lechner, Peter
    Nuehrenberg, Thomas
    Zeller, Thomas
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (17) : 2052 - 2061
  • [26] Diabetes mellitus and femoropopliteal in-stent restenosis: Insights from the dRug-coatEd balloon angioPlasty for femoropopliteAl In-stent Restenosis cooperation
    Voll, Felix
    Wolf, Florian
    Ingwersen, Maja
    Kinstner, Christian M.
    Kufner, Sebastian
    Ibrahim, Tareq
    Ott, Ilka
    Krankenberg, Hans
    Fusaro, Massimiliano
    Cassese, Salvatore
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2022, 51 (04) : 247 - 255
  • [27] Risk Factors for Restenosis after Drug-coated Balloon Angioplasty for Complex Femoropopliteal Arterial Occlusive Disease
    Roh, Ji Woong
    Ko, Young-Guk
    Ahn, Chul-Min
    Hong, Sung-Jin
    Shin, Dong-Ho
    Kim, Jung-Sun
    Kim, Byeong-Keuk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    ANNALS OF VASCULAR SURGERY, 2019, 55 : 45 - 54
  • [28] Debulking plus drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions
    Li, Liqiang
    Tong, Zhu
    Cui, Shijun
    Guo, Lianrui
    VIDEOSURGERY AND OTHER MINIINVASIVE TECHNIQUES, 2023, 18 (01) : 166 - 172
  • [29] Gender Differences in the Outcomes of Drug-Coated Balloon Treatment in Symptomatic Femoropopliteal Arterial Disease
    Krishnan, Prakash
    Tarricone, Arthur
    Purushottam, Bhaskar
    Chen, Simon
    Kapur, Vishal
    Gujja, Karthik
    Kini, Annapoorna
    Sharma, Samin
    VASCULAR AND ENDOVASCULAR SURGERY, 2020, 54 (04) : 348 - 354
  • [30] Impact of a Less Than 50% Residual Stenosis Following Vessel Preparation in Femoropopliteal Drug-Coated Balloon Angioplasty
    Tomoi, Yusuke
    Soga, Yoshimitsu
    Imada, Kazuaki
    Sakai, Nobuaki
    Katsuki, Tomonori
    Ando, Kenji
    JOURNAL OF ENDOVASCULAR THERAPY, 2024,